Total Funding
71
9
Total FundingDebt Financing raised
Growth Score
-6 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
526632
Coridea is a medical device incubator that develops solutions that change the lives of cardio, pulmonary and renal patients.
- Adam Rosenwach: Partner and Chief Business OfficerPast Role: CorVent Medical, Co-Founder and Chief Financial Officer
- Howard Levin: President and Chief Scientific OfficerPast Role: Evalve, Vice President of R&D
About the Company
CORIDEA is an idea generator, technology incubator and consulting firm that applies established technologies to new targets in the cardio-renal and cardio-pulmonary fields. Since its inception in 2003, Coridea has launched six startup companies including Ardian, CHF Solutions, and Respicardia (formerly, Cardiac Concepts). The $800 MM acquisition of
Ardian by Medtronic marked the highest-priced venture capital-backed pre-revenue medical device acquisition to date. With 65 U.S. patents licensed by companies such as Evalve, Zoll Medical, Nephros, and PLC Medical; over $150 million in venture capital financing; and the invention of 2011 Edison Award-winning Symplicity® Catheter System™, Coridea is a leader in medical device innovation.
